Maria Benito-Lopez

Leon, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial.

Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial.

Journal: Heart (British Cardiac Society)

Published: January 20, 2025

A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study.

A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study.

Journal: JACC. Cardiovascular interventions

Published: October 24, 2023

Safety and feasibility of transradial access for percutaneous coronary intervention in chronic total occlusions.

Safety and feasibility of transradial access for percutaneous coronary intervention in chronic total occlusions.

Journal: Revista espanola de cardiologia (English ed.)

Published: February 01, 2022

Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial. An intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stent.

Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial. An intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stent.

Journal: International journal of cardiology

Published: December 02, 2021

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.

Journal: European heart journal

Published: October 04, 2021

Development and Evaluation of a Disease Large Animal Model for Preclinical Assessment of Renal Denervation Therapies.

Development and Evaluation of a Disease Large Animal Model for Preclinical Assessment of Renal Denervation Therapies.

Journal: Animals : an open access journal from MDPI

Published: August 11, 2020

Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design.

Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design.

Journal: American heart journal

Published: September 20, 2019

Safety and Efficacy of New Biodegradable Polymer-based Sirolimus-Eluting Stents in a Preclinical Model.

Safety and Efficacy of New Biodegradable Polymer-based Sirolimus-Eluting Stents in a Preclinical Model.

Journal: Revista espanola de cardiologia (English ed.)

Published: November 12, 2016

Sensationalist Headlines: Also in the Scientific Press?

Sensationalist Headlines: Also in the Scientific Press?

Journal: Revista espanola de cardiologia (English ed.)

Published: September 21, 2015

Safety and Efficacy of New Sirolimus-eluting Stent Models in a Preclinical Study.

Safety and Efficacy of New Sirolimus-eluting Stent Models in a Preclinical Study.

Journal: Revista espanola de cardiologia (English ed.)

Published: December 17, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026